Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Scott Hagan"


5 mentions found


How Ozempic Is Changing Diabetes Treatment
  + stars: | 2024-05-13 | by ( Dani Blum | ) www.nytimes.com   time to read: +1 min
Day in and day out, she carefully calibrated the doses needed to keep her Type 2 diabetes in check. “Every meal, and every morning and every night — it controls your life,” she said. In late 2021, she started on the diabetes drug Ozempic. She still uses a continuous glucose monitor to track her blood sugar, meticulously watching for slumps and spikes — but even as she took less insulin, she said, Ozempic has helped keep her glucose levels more under control. Millions of Americans rely on some form of insulin, a lifesaving drug that has long been a mainstay of diabetes treatment.
Persons: Betsy Chadwell, , Ozempic, Chadwell, , Scott Hagan Organizations: University of Washington
When Ms. Coombes, 41, sat down to eat very small portions, an interrogation broke out at the Thanksgiving table. “There was a lot of ‘Why aren’t you eating?’ or ‘Why isn’t there more on your plate?’” she said. That reality has sent many people who take Ozempic and similar drugs into preparation mode. Dr. Scott Hagan, an assistant professor of medicine at the University of Washington who studies obesity, said patients ask him if they can skip doses of Ozempic or similar drugs before a food-focused event like Thanksgiving. He advises them not to, for a few reasons: For people with diabetes, missing a dose of Ozempic and then consuming a high-carb meal could lead to a blood sugar spike.
Persons: Coombes, , Amy Bentley, Bentley, Scott Hagan Organizations: New York University, University of Washington
You Won’t Lose Weight on Ozempic Forever
  + stars: | 2023-09-18 | by ( Dani Blum | More About Dani Blum | ) www.nytimes.com   time to read: +2 min
But doctors say some people seek out these drugs to lose as much weight as possible — and are dismayed and disillusioned when they stop. When they do, they tend to regain the weight they lost. Medications like Ozempic mimic a naturally occurring hormone and slow the emptying of the stomach, so that we feel fuller, faster and for longer. In clinical trials of semaglutide, the compound in Ozempic and Wegovy, people with diabetes have tended to lose less weight, less quickly, than people who did not have the condition, Dr. Hagan said. A small proportion of those who take these drugs won’t lose weight at all, he added.
Persons: ” Ms, Meinecke, Scott Hagan, Hagan, Andrew Kraftson Organizations: University of Washington, Michigan Medicine
That’s particularly a concern for older adults, obesity medicine experts say. The more muscle someone over the age of 65 loses, the greater their risk of becoming frail or suffering a fracture or fall (which can be fatal in older adults). It is crucial for older adults to maintain muscle mass so that they can stay mobile and independent. Muscle mass naturally dwindles with age. Clinical trials on semaglutide, the active ingredient in Ozempic and Wegovy, have typically enrolled people in their 40s and 50s.
Persons: — you’re, Scott Hagan, Janice Jin Hwang Organizations: University of Washington, University of North Carolina School of Medicine
The American Medical Association voted to adopt a new policy on Tuesday encouraging doctors not to rely only on body mass index, a long-used but potentially misleading metric, when assessing weight and health. The policy officially recognizes the “historical harm” of B.M.I. is influential in the medical community, the new recommendation is just a suggestion to doctors, not a strict rule they must comply with. The association, one of the largest medical groups in the country, will now recommend that doctors not use B.M.I. alone to assess whether a patient is at a healthy weight.
Persons: , Cynthia Romero, Brock, Scott Hagan, Organizations: American Medical Association, Brock Institute for Community, Global Health, Eastern Virginia Medical School, University of Washington
Total: 5